Matches in Nanopublications for { ?s ?p "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP341293.RAMSzHQXMCh-DRvI-TAxcEHXWAHH7yOBkofzC58hdV49I130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341293.RAMSzHQXMCh-DRvI-TAxcEHXWAHH7yOBkofzC58hdV49I130_provenance.
- NP271028.RAYlhMD0uiCxDAS8PDwUwDUJh8CS4KWIdkxrQW0eV9sTE130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271028.RAYlhMD0uiCxDAS8PDwUwDUJh8CS4KWIdkxrQW0eV9sTE130_provenance.
- NP273283.RAWq_9vahFmBPfoZGcwFFjiIzvEJoMvrsi-l5DptzmpEU130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273283.RAWq_9vahFmBPfoZGcwFFjiIzvEJoMvrsi-l5DptzmpEU130_provenance.
- NP667480.RAC5PiLaLSWueivrtp7w_3AU2qfrxmMEJ8fCEwKn7LIug130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667480.RAC5PiLaLSWueivrtp7w_3AU2qfrxmMEJ8fCEwKn7LIug130_provenance.
- NP271057.RAzLRQcwln5M02ok-PO9KVkRt-daNlge7RGiwH_R8MlYE130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271057.RAzLRQcwln5M02ok-PO9KVkRt-daNlge7RGiwH_R8MlYE130_provenance.
- assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP667479.RAfm5Q56qmfwPnsfCUQpU8uudo6Pn_qiT1Zbd7iI2XH70130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667479.RAfm5Q56qmfwPnsfCUQpU8uudo6Pn_qiT1Zbd7iI2XH70130_provenance.
- NP667481.RAtLRJ_lJT5qqA6MokjIiyENv-zcDq1k6DmPUdU6_3lsQ130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667481.RAtLRJ_lJT5qqA6MokjIiyENv-zcDq1k6DmPUdU6_3lsQ130_provenance.
- NP667482.RAtvYt_2g42ZXLZ8TEuhSNlhjEIi6L0GmdH2Ee5OllV8c130_assertion description "[In summary, we advise restricting BRCA1 MLPA screening to those subgroups that revealed LGRs and recommend BRCA2 MLPA screening only for families presenting with cooccurrence of female and male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667482.RAtvYt_2g42ZXLZ8TEuhSNlhjEIi6L0GmdH2Ee5OllV8c130_provenance.